Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Title

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Authors

Keywords

-

Journal

LANCET ONCOLOGY

Volume 16, Issue 9, Pages 1071-1078

Publisher

Elsevier BV

Online

2015-08-11

DOI

10.1016/s1470-2045(15)00034-0